Suzanne Borgel

Schedule-dependent Inhibition of Hypoxia-inducible Factor-1α Protein Accumulation, Angiogenesis, and Tumor Growth by Topotecan in U251-HRE Glioblastoma Xenografts

Annamaria Rapisarda, J. Zalek, Melinda G. Hollingshead et al. · Cancer Research · 2004 · 187 citations

Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition

Annamaria Rapisarda, Melinda G. Hollingshead, Badarch Uranchimeg et al. · Molecular Cancer Therapeutics · 2009 · 168 citations · Full text

Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC

Luke H. Stockwin, Sherry X. Yu, Suzanne Borgel et al. · International Journal of Cancer · 2010 · 156 citations

In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative

Melinda G. Hollingshead, Michael C. Alley, Angelika M. Burger et al. · Cancer Chemotherapy and Pharmacology · 2005 · 150 citations

Medicinal Chemistry, Water-soluble Geldanamycin Derivative, Oncology +5

Clinical Evolution of Epithelial–Mesenchymal Transition in Human Carcinomas

Tony Navas, Robert J. Kinders, Scott M. Lawrence et al. · Cancer Research · 2019 · 96 citations · Full text